{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:32Z","timestamp":1787032772122,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,20]]},"DOI":"10.7759\/cureus.84498","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T20:15:23Z","timestamp":1747772123000},"source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic Cancer Presenting With Hematemesis and Hemorrhagic Shock Following Anticoagulation With Unfractionated Heparin for Cancer-Related Venous Thromboembolism"],"prefix":"10.7759","author":[{"given":"Mayuko","family":"Tagaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Irisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon AR","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al.. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022, 43:4229-361. 10.1093\/eurheartj\/ehac244","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana AA","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007, 5:632-4. 10.1111\/j.1538-7836.2007.02374.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03716-0","article-title":"Cancer-associated thrombosis and bleeding","volume":"119","author":"Ikezoe T","year":"2024","unstructured":"Ikezoe T. Cancer-associated thrombosis and bleeding. Int J Hematol. 2024, 119:493-4. 10.1007\/s12185-024-03716-0","journal-title":"Int J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted F","year":"2012","unstructured":"Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012, 9:e1001275. 10.1371\/journal.pmed.1001275","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-13-0886","article-title":"Current venous thromboembolism management and outcomes in Japan","volume":"78","author":"Nakamura M","year":"2014","unstructured":"Nakamura M, Miyata T, Ozeki Y, et al.. Current venous thromboembolism management and outcomes in Japan. Circ J. 2014, 78:708-17. 10.1253\/circj.cj-13-0886","journal-title":"Circ J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.06.033","article-title":"Epidemiology of venous thromboembolism in the Framingham Heart Study","volume":"145","author":"Puurunen MK","year":"2016","unstructured":"Puurunen MK, Gona PN, Larson MG, Murabito JM, Magnani JW, O'Donnell CJ. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016, 145:27-33. 10.1016\/j.thromres.2016.06.033","journal-title":"Thromb Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni P","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, et al.. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002, 100:3484-8. 10.1182\/blood-2002-01-0108","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides SV","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G, et al.. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014, 35:3033-69, 3069a-3069k. 10.1093\/eurheartj\/ehu283","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases","volume":"49","author":"Walker AJ","year":"2013","unstructured":"Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2013, 49:1404-13. 10.1016\/j.ejca.2012.10.021","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02033-3","article-title":"Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort","volume":"58","author":"Okusaka T","year":"2023","unstructured":"Okusaka T, Saiura A, Shimada K, et al.. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort. J Gastroenterol. 2023, 58:1261-71. 10.1007\/s00535-023-02033-3","journal-title":"J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen HT","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000, 343:1846-50. 10.1056\/NEJM200012213432504","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.0984","article-title":"Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients","volume":"29","author":"den Exter PL","year":"2011","unstructured":"den Exter PL, Hooijer J, Dekkers OM, Huisman MV. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol. 2011, 29:2405-9. 10.1200\/JCO.2010.34.0984","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob GE","year":"2018","unstructured":"Raskob GE, van Es N, Verhamme P, et al.. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018, 378:615-24. 10.1056\/NEJMoa1711948","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.11.004","article-title":"Editor's choice - a systematic review and meta-analysis of the efficacy and safety of anticoagulation in the treatment of venous thromboembolism in patients with cancer","volume":"57","author":"Kirkilesis GI","year":"2019","unstructured":"Kirkilesis GI, Kakkos SK, Tsolakis IA. Editor's choice - a systematic review and meta-analysis of the efficacy and safety of anticoagulation in the treatment of venous thromboembolism in patients with cancer. Eur J Vasc Endovasc Surg. 2019, 57:685-701. 10.1016\/j.ejvs.2018.11.004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli G","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, et al.. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020, 382:1599-607. 10.1056\/NEJMoa1915103","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14623","article-title":"Association of risk factors and bleeding complications in Asian patients taking edoxaban","volume":"87","author":"Lee OS","year":"2021","unstructured":"Lee OS, Kim W, Jang BM, Min KH, Cho YS, Lee MK, Lee KE. Association of risk factors and bleeding complications in Asian patients taking edoxaban. Br J Clin Pharmacol. 2021, 87:2121-7. 10.1111\/bcp.14623","journal-title":"Br J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ru\u00edz-Gim\u00e9nez N","year":"2008","unstructured":"Ru\u00edz-Gim\u00e9nez N, Su\u00e1rez C, Gonz\u00e1lez R, Nieto JA, Todol\u00ed JA, Samperiz AL, Monreal M. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost. 2008, 100:26-31. 10.1160\/TH08-03-0193","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1729171","article-title":"Prediction of major bleeding in anticoagulated patients for venous thromboembolism: comparison of the RIETE and the VTE-BLEED scores","volume":"5","author":"Lecumberri R","year":"2021","unstructured":"Lecumberri R, Jim\u00e9nez L, Ruiz-Artacho P, et al.. Prediction of major bleeding in anticoagulated patients for venous thromboembolism: comparison of the RIETE and the VTE-BLEED scores. TH Open. 2021, 5:e319-28. 10.1055\/s-0041-1729171","journal-title":"TH Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361434-pancreatic-cancer-presenting-with-hematemesis-and-hemorrhagic-shock-following-anticoagulation-with-unfractionated-heparin-for-cancer-related-venous-thromboembolism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T20:15:24Z","timestamp":1747772124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361434-pancreatic-cancer-presenting-with-hematemesis-and-hemorrhagic-shock-following-anticoagulation-with-unfractionated-heparin-for-cancer-related-venous-thromboembolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.84498","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}